Evaluation Study of SPOTme® Skin Cancer Screenings

President and Fellows of Harvard College

Status: Completed

Conditions: Skin Cancer

Treatments: Other: AAD SPOTmeⓇ skin cancer screening; Behavioral: Intervention Arm

Study type: Interventional

Funder types: Other

Identifiers

NCT03564769

17-1668

Details and patient eligibility

About

This study evaluates the impact of the AAD SPOTme® skin cancer screening events on attendees' skin cancer prevention and detection behaviors. This study will also evaluate whether an educational intervention will improve post-screening engagement of attendees with dermatologists.

Full description

Despite tremendous growth in both the interest and volume of skin cancer screenings at the national level, the actual utility and impact of the AAD SPOT me™ skin cancer screening programs have not been fully evaluated. This study will address this knowledge gap. Early detection is vital in the fight against skin cancer, the most common cancer in the United States. While the effects of skin cancer can be devastating, this disease is highly treatable when detected early.

This study evaluates the impact of the AAD SPOTme® skin cancer screening events on attendees' skin cancer prevention and detection behaviors. This study will also evaluate whether an educational intervention will improve post-screening engagement of attendees with dermatologists.

Enrollment: 431 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participated in the American Academy of Dermatology national screening program in 2016 or 2017
• Have a presumptive diagnosis (screening, non-confirmed) of melanoma
• Have provided the AAD with permission to be re-contacted
• Have provided the AAD with an email address
• Aged 18 years or older
• Able to read English

Exclusion criteria

• None

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

431 participants in 2 patient groups

Intervention Arm 1

Experimental group

Description:

Individuals randomized to intervention group 1 will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017 AND will receive additional skin cancer screening educational materials.

Treatment:

Other: AAD SPOTmeⓇ skin cancer screening

Behavioral: Intervention Arm

Intervention Arm 2

Experimental group

Description:

Individuals randomized to intervention group 2 will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017 only.

Treatment:

Other: AAD SPOTmeⓇ skin cancer screening